MediWound Reports Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
MediWound (MDWD) Tops Q3 EPS by 14c, Revenues Beat
November 14, 2019 7:05 AM ESTMediWound (NASDAQ: MDWD) reported Q3 EPS of ($0.01), $0.14 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $5.1 million versus the consensus estimate of $2.08 million.
Business and Financial Highlights for the Third Quarter 2019 and Recent Weeks include:
Total revenues for the third quarter of 2019 were $5.1, driven primarily by revenues from development services; As of September 30, 2019, the Company had $32.9 million in cash and short-term investments, compared to $23.6 million as of December 31, 2018; Initiated the NexoBrid Expanded Access Treatment (NEXT) protocol to treat burn patients with deep partial... More